Abivax Sa American Stock Today
| ABVX Stock | 6.84 0.04 0.59% |
PerformanceVery Weak
| Odds Of DistressBelow Average
|
Abivax SA is trading at 6.84 as of the 20th of March 2025; that is 0.59 percent up since the beginning of the trading day. The stock's open price was 6.8. Abivax SA has about a 31 percent probability of financial distress in the next few years of operation and has generated negative returns over the last 90 days. The performance scores are derived for the period starting the 20th of December 2024 and ending today, the 20th of March 2025. Click here to learn more.
Moving against Abivax Stock
Follow Valuation Odds of Bankruptcy
Check how we calculate scores
Abivax Stock Highlights
| Business Concentration | Pharmaceutical Products, Biotechnology, Healthcare, Health Care, Biotechnology, Biotechnology, Healthcare (View all Sectors) |
Abivax SA American (ABVX) is traded on NASDAQ Exchange in USA. It is located in 7-11 boulevard Haussmann, Paris, France, 75009 and employs 62 people. Abivax SA is listed under Pharmaceutical Products category by Fama And French industry classification. The company currently falls under 'Small-Cap' category with a current market capitalization of 649.94 M. Abivax SA American conducts business under Biotechnology sector and is part of Health Care industry. The entity has 62.92 M outstanding shares of which 1.15 M shares are presently shorted by private and institutional investors with about 1.14 trading days to cover.
Abivax SA generates negative cash flow from operations
Check Abivax SA Probability Of Bankruptcy
Ownership AllocationAbivax SA holds a total of 62.92 Million outstanding shares. 30% of Abivax SA American outstanding shares are owned by other corporate entities. Institutional investors are typically referred to investors that purchase positions in a given stock to benefit from reduced commissions. Consequently, institutional investors are subject to different rules and regulations than regular investors. Please look out for any change in current institutional holding as this could mean something significant has changed at the company or is about to change. Please note that no matter how many assets the company secures, if the real value of the firm is less than the current market value, you may not be able to make money on it.
Check Abivax Ownership Details
Abivax SA American Risk Profiles
Investors will always prefer to have the highest possible return on investment while minimizing volatility. Abivax SA market risk premium is the additional return an investor will receive from holding Abivax SA long position in a well-diversified portfolio.
| Risk Adjusted Performance | (0.01) | |||
| Jensen Alpha | (0.11) | |||
| Total Risk Alpha | 0.2788 | |||
| Treynor Ratio | 0.4692 |
Abivax Stock Against Markets
Abivax SA Corporate Management
| Chris Rabbat | VP Affairs | Profile | |
| Ana MPH | VP Quality | Profile | |
| MBA BS | Chief Officer | Profile | |
| Jrme Denis | Executive Manufacturing | Profile | |
| Patrick Malloy | Senior Relations | Profile | |
| Didier Scherrer | Chief Officer | Profile |
Already Invested in Abivax SA American?
The danger of trading Abivax SA American is mainly related to its market volatility and Company specific events. As an investor, you must understand the concept of risk-adjusted return before you start trading. The most common way to measure the risk of Abivax SA is by using the Sharpe ratio. The ratio expresses how much excess return you acquire for the extra volatility you endure for holding a more risker asset than Abivax SA. The Sharpe ratio is calculated by using standard deviation and excess return to determine reward per unit of risk. To understand how volatile Abivax SA American is, you must compare it to a benchmark. Traditionally, the risk-free rate of return is the rate of return on the shortest-dated U.S. Treasury, such as a 3-year bond.
Additional Tools for Abivax Stock Analysis
When running Abivax SA's price analysis, check to measure Abivax SA's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Abivax SA is operating at the current time. Most of Abivax SA's value examination focuses on studying past and present price action to predict the probability of Abivax SA's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Abivax SA's price. Additionally, you may evaluate how the addition of Abivax SA to your portfolios can decrease your overall portfolio volatility.